Diabetogenic hyperinsulinism: pathogenesis and implications of sulfonylurea-induced hypothyroidism.
D000328:Adult; D002784:Cholesterol; D048909:Diabetes Complications; D004035:Diet Therapy; D005260:Female; D005951:Glucose Tolerance Test; D006042:Goiter / Q000150:complications; D006073:Gout / Q000188:drug therapy; D006801:Humans; D006946:Hyperinsulinism / Q000209:etiology; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D007037:Hypothyroidism / Q000139:chemically induced*; D010629:Phenformin / Q000494:pharmacology; D013960:Thyroid Function Tests; D014044:Tolbutamide / Q000009:adverse effects; D014308:Triparanol / Q000494:pharmacology
D007004:Hypoglycemic Agents; D014308:Triparanol; D002784:Cholesterol; D014044:Tolbutamide; D010629:Phenformin